|By Marketwired .||
|June 23, 2014 08:15 AM EDT||
LOS ANGELES, CA -- (Marketwired) -- 06/23/14 -- MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), appeared Wednesday, June 18 in the United States District Court, Central District of California, where plaintiff MyMedicalRecords, Inc., and defendant(s) Quest Diagnostics, Inc., Empty Jar, LLC f/k/a Jardogs, LLC, Allscripts Healthcare Solutions, Inc., WebMD Health Corp. and WebMD Health Services Group, appeared before the Honorable Otis D. Wright, II to provide both the plaintiff's and the defendants' tutorial of the technology at issue in the cases. MMR focused its technology tutorial on the invention including a demonstration of the technology as available on MyMedicalRecords.com. The tutorials were designed to assist the Court in understanding the nature and operation of the invention covered by the two MMR Personal Health Record patents at issue in the litigation, specifically, U.S. Patent Nos. 8,301,466 and 8,498,883. The tutorials were part of the Markman proceedings designed to interpret disputes in patent claim language. The Markman process also includes the filing of opening, opposition and reply claim construction briefs which will be the subject of a scheduled August 19th, 2014 Markman hearing before Judge Wright.
Attorneys for MMR made the presentation with MMR Chief Executive Officer and patent inventor Robert H. Lorsch. During the presentation, MMR showed the Court samples of its new MyMedicalRecords Personal Health Record Kit which was created for sale at retail following the signing of patent license and retail sales agreements with retailers representing more than 40 million customers starting this summer. The Company also plans on announcing licensing and settlement agreements with PHR and EMR vendors prior to an upcoming new business trip to Australia next week.
In his presentation, Lorsch recounted his story as a cancer survivor and the challenging environment in healthcare that existed prior to 2005. As a result, he invented the comprehensive product that now makes it possible for medical consumers to access, collect and manage their medical records, including prescriptions, online in a secure and private manner. The product is also designed to achieve seamless interoperability with one consolidated medical record for patients and all their family members regardless of the number of physicians and the technology on the other end of the PHR. He pointed out that MMR's technology provides patients, any number of treating doctors, and other medical personnel (including emergency room physicians and staff) access to complete, secure and private medical information whenever and wherever it's needed from anywhere in the world. MMR's technology, he noted, can reduce healthcare costs, eliminate unnecessary duplicate testing and delays in obtaining treatment, as well as other wasteful and potentially dangerous practices facing patients.
In addition to providing background into the invention, Lorsch's presentation also included an account of a family with multiple family members including Charlie Brown, the family pet. Lorsch also spoke of his own personal experience using the MyMedicalRecords PHR to manage his health, and help avert an operation, by transmitting his own emergency medical records when he was hospitalized not long ago. His experience is described in detail on the MMRGlobal blog Home from the Hospital which is available at http://blog.mmrglobal.com/2013/11/25/home-from-the-hospital/.
MyMedicalRecords, Inc. is a practicing entity and a leading provider of secure and easy-to-use Personal Health Records through its MyMedicalRecords PHR, and MMRPro and MMRProPlus document management and imaging systems for healthcare professionals. MMR also offers MyEsafeDepositBox, which provides an online site to securely store important legal, financial, insurance and other important documents, as well as medical and personal health information. MMR's global health information technology patent portfolio includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532; 8,645,161 and 8,725,537, which collectively include over 275 issued claims, along with additional applications and continuation applications pending. MMR has also received notice from the United States Patent and Trademark Office that its 12th domestic patent, U.S. Patent No. 8,768,725, is being issued, and a Notice of Allowance, Serial No. 13/082,896, was recently received for an additional patent. The most recent NOA represents MMR's first Clinical Trials patent and includes 18 claims directed to methods and systems that provide for self-reporting being used to create Electronic Health Records for purposes including Clinical Trials. Additionally, MMR has received issued patents and has pending applications in 11 other countries or regional authorities of commercial interest including Australia, Canada, Singapore, New Zealand, Mexico, Hong Kong, China, Japan, South Korea, Israel, and Europe.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId/Specifid vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com. Follow us at Facebook.com/MMRGlobal and Twitter.com/mmrglobal.
All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property licenses, intellectual property enforcement actions, infringement claims or litigation, and future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, license, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Public Communications Co.
Aug. 29, 2016 02:15 PM EDT Reads: 3,731
Aug. 29, 2016 02:00 PM EDT Reads: 957
Aug. 29, 2016 02:00 PM EDT Reads: 2,475
Aug. 29, 2016 01:01 PM EDT Reads: 206
Aug. 29, 2016 12:45 PM EDT Reads: 2,019
Aug. 29, 2016 12:15 PM EDT Reads: 815
Aug. 29, 2016 12:00 PM EDT Reads: 862
Aug. 29, 2016 12:00 PM EDT Reads: 3,187
Aug. 29, 2016 12:00 PM EDT Reads: 821
Aug. 29, 2016 08:15 AM EDT Reads: 738
Aug. 29, 2016 08:00 AM EDT Reads: 847
Aug. 29, 2016 08:00 AM EDT Reads: 938
Aug. 29, 2016 07:30 AM EDT Reads: 818
Aug. 29, 2016 03:00 AM EDT Reads: 2,429
Aug. 29, 2016 02:15 AM EDT Reads: 1,838